Client News
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
LINDIS Biotech Announces Formation of Advisory Board to Support Next Phase of Growth
ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2022
Atriva Therapeutics: Participation in upcoming scientific and industry conferences
VisionHealth receives EU Medical Device Regulation certification
MagForce AG: Enrollment in Stage 2b of Pivotal U.S. Study for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System successfully underway following IRB approval
invIOs goes live with unique cell therapy platform and clinical-stage immuno-oncology pipeline
Patronus Health GmbH Receives Angel Investment and Public Grant
sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010 in moderate to severe asthma
